Epstein-Barr virus
Coverage of Epstein-Barr virus in the Nexus archive.
- 95% of people carry this virus and scientists may have just found how to stop it
Scientists have developed human-like antibodies that block Epstein-Barr virus (EBV) from infecting immune cells, with one antibody completely preventing infection in lab models. EBV, which affects 95% of people, is linked to cancer and chronic diseases, and this breakthrough marks progress in tackling its widespread impact.
- EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk
A genome-to-genome association study published in Nature identifies how interactions between Epstein-Barr virus strains and host HLA genes contribute to nasopharyngeal carcinoma risk in southern China. The research highlights key host and viral factors driving the endemicity of the disease in the region.
- Hidden human–virus interactions uncovered in DNA in blood and saliva
A study published in Nature reveals viral DNA abundance in blood and saliva correlates with age, sex, and genetic variants. High Epstein-Barr virus levels are linked to Hodgkin’s lymphoma as a causal risk factor.